Table 2.
Effects of genetic manipulations of angiotensin II receptors on development of atherosclerosis in mice
Receptor deficiency | Model | Gender | Atherosclerosis effect | Study |
---|---|---|---|---|
Whole body deficiency | ||||
AT1a | LDL receptor -/- | Male and female | Decrease | Daugherty et al. [11] |
apoE -/- | Male | Decrease | Wassmann et al. [27] | |
Decrease | Li et al. [28] | |||
Decrease | Tomono et al. [30] | |||
Decrease | Eto et al. [29] | |||
Diabetic apoE-/- | Decrease | Ihara et al. [33] | ||
AT2 | LDL receptor -/- | Male and female | No effect | Daugherty et al. [11] |
apoE-/- | Male | Increase | Iwai et al. [39] | |
No effect on size, but composition change | Sales et al. [38] | |||
Diabetic apoE-/- | Decrease | Koitka et al. [37] | ||
Bone marrow transplantation | ||||
AT1a | LDL receptor -/-; AngII infused | Male | No effect in AT1aR -/-; modest decrease in +/+ | Cassis et al. [31] |
apoE -/-; AngII infused | No effect in AT1aR -/-; modest decrease in +/+ | Koga et al. [35] | ||
LDL receptor -/- | No effect | Lu et al. [7•] | ||
apoE -/- | Decrease | Fukuda et al. [32] | ||
Decrease | Tsubakimoto et al. [34] | |||
Increase | Kato et al. [36] |
AngII angiotensin II, apoE apolipoprotein E, LDL low-density lipoprotein